Literature DB >> 24346160

The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy.

Hai Wang1, Yu-Chen Du, Xiao-Jun Zhou, Hong Liu, Shou-Ching Tang.   

Abstract

The major functions of Hippo (Hpo) signaling pathway are to control cell growth, proliferation, and apoptosis. As its important downstream player, yes-associated protein (YAP)-1 was originally found to promote cell proliferation and transformation. Overexpression of YAP-1 has been linked to tumor progression and worse survival in certain malignancies. However, it has been recently recognized as a tumor suppressor gene as well since it also induces apoptosis. Decreased or absent expression of YAP-1 is highly correlated with tumor progression and worse survival in other tumors such as breast cancer. It is clear that YAP-1 plays a dual role as oncogene and tumor suppressor gene in human oncogenesis, depending on the specific tissue type involved. Here, we reviewed the recent research on both the oncogenic and tumor suppressor function of YAP-1 and its significance in human malignancy. The clinical implication of YAP-1 expression in cancer prognosis and the development of targeted therapy will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24346160     DOI: 10.1007/s10555-013-9463-3

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  30 in total

Review 1.  YAP and the Hippo pathway in pediatric cancer.

Authors:  Atif A Ahmed; Abdalla D Mohamed; Melissa Gener; Weijie Li; Eugenio Taboada
Journal:  Mol Cell Oncol       Date:  2017-02-25

2.  The large tumor suppressor family: friend or foe?

Authors:  Wei Kang; Yuhang Zhou; Ka Fai To
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.

Authors:  Toshiro Moroishi; Tomoko Hayashi; Wei-Wei Pan; Yu Fujita; Matthew V Holt; Jun Qin; Dennis A Carson; Kun-Liang Guan
Journal:  Cell       Date:  2016-12-01       Impact factor: 41.582

Review 4.  An overview of the crosstalk between YAP and cGAS-STING signaling in non-small cell lung cancer: it takes two to tango.

Authors:  Fang Hao
Journal:  Clin Transl Oncol       Date:  2022-04-03       Impact factor: 3.340

5.  Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.

Authors:  Cecile Rouleau; Arun T Pores Fernando; Justin H Hwang; Nathalie Faure; Tao Jiang; Elizabeth A White; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

Review 6.  The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review.

Authors:  Anastasios Kyriazoglou; Michalis Liontos; Roubini Zakopoulou; Maria Kaparelou; Anna Tsiara; Alkistis Maria Papatheodoridi; Rebecca Georgakopoulou; Flora Zagouri
Journal:  Breast Care (Basel)       Date:  2020-05-12       Impact factor: 2.860

7.  A miR-375/YAP axis regulates neuroendocrine differentiation and tumorigenesis in lung carcinoid cells.

Authors:  Xiaojing Yang; Jina Nanayakkara; Duncan Claypool; Sadegh Saghafinia; Justin J M Wong; Minqi Xu; Xiantao Wang; Christopher J B Nicol; Iacovos P Michael; Markus Hafner; Xiaolong Yang; Neil Renwick
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

8.  Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic Significance.

Authors:  Atif A Ahmed; Malak Abedalthagafi; Ahmed E Anwar; Marilyn M Bui
Journal:  J Cancer       Date:  2015-08-22       Impact factor: 4.207

9.  Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer.

Authors:  Masahiro Tsujiura; Virginia Mazack; Marius Sudol; Hanna G Kaspar; John Nash; David J Carey; Radhika Gogoi
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

Review 10.  The role of the Hippo pathway in human disease and tumorigenesis.

Authors:  Daniel A Barron; Jacob D Kagey
Journal:  Clin Transl Med       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.